GIMBERT JOAN PONS 4
4 · MANHATTAN PHARMACEUTICALS INC · Filed Feb 2, 2007
Insider Transaction Report
Form 4
GIMBERT JOAN PONS
Director
Transactions
- Award
Common Stock
2007-01-30+2,112→ 2,112 total - Award
Director Stock Option
2007-01-30+50,000→ 50,000 totalExercise: $0.71Exp: 2017-01-30→ Common Stock (50,000 underlying)
Holdings
- 25,000
Director Stock Option
Exercise: $1.00Exp: 2015-01-11→ Common Stock (25,000 underlying) - 3,957,037(indirect: By Oleoyl-Estrone Developments SL)
Common Stock
- 75,000
Option
Exercise: $1.65Exp: 2014-01-27→ Common Stock (75,000 underlying)
Footnotes (6)
- [F1]The Reporting Person is the chief executive officer of Oleoyl-Estrone Developments SL, a company of unlimited duration registered in the Registro Mercantil of Carcelona ("OED"). The Reporting Person disclaims beneficial Ownership of the shares owned by OED.
- [F2]Under the 2003 Stock Option Plan.
- [F3]Stock issued in lieu of Director's fees due; based on closing stock price on January 30, 2007.
- [F4]25,000 shares have vested. 25,000 shares vest, if at all, on 1/28/05 and 1/28/06, respectively.
- [F5]8,334 shares vest on 1/11/05, 8,333 shares vest on each of 1/11/06 and 1/11/07.
- [F6]16,667 shares vest on each of 1/30/07 and 1/30/08; 16,666 shares vest on 1/30/09.